论文信息 - Humoral and T cell Responses to SARS-CoV-2 Vaccine Booster and Anti-SARS-CoV-2 Monoclonal Antibodies in Patients With End-Stage Kidney Disease - 字舞流文

Humoral and T cell Responses to SARS-CoV-2 Vaccine Booster and Anti-SARS-CoV-2 Monoclonal Antibodies in Patients With End-Stage Kidney Disease

G. Stallone | P. Cravedi | G. Zaza | C. Rollenhagen | J. Maltzman | S. Granata | M. Gentile | Sofia Bin | Maddalena Panico | Lin Wang

[1] L. Riella,et al. Antibody Responses Against Emerging SARS-CoV-2 Omicron Lineages After the Fourth Dose of mRNA Vaccine in Kidney Transplant Recipients , 2023, Transplantation.

[2] S. Klein,et al. Persistent SARS-CoV-2–specific immune defects in kidney transplant recipients following third mRNA vaccine dose , 2023, American Journal of Transplantation.

[3] O. Keppler,et al. Immunologic Effect of Bivalent mRNA Booster in Patients Undergoing Hemodialysis , 2023, The New England journal of medicine.

[4] N. Kamar,et al. Absence of Mortality Differences Between the First and Second COVID-19 Waves in Kidney Transplant Recipients , 2022, Kidney International Reports.

[5] H. Tedesco-Silva,et al. The Higher COVID-19 Fatality Rate Among Kidney Transplant Recipients Calls for Further Action. , 2022, Transplantation.

[6] J. Morley,et al. Geriatric Research, Education and Clinical Centers: Their Impact in the Development of American Geriatrics , 1994, Journal of the American Geriatrics Society.